Companies:
53,025
Total Market Cap:
168993657296421.08
Harvard Bioscience
NASDAQ: HBIO
Healthcare
Medical Instruments & Supplies
Global Rank
#35211
Country Rank
#4647
Market Cap
29.32 M
Price
6.5
Change (%)
0.62%
Volume
28,567
Harvard Bioscience's latest marketcap:
29.32 M
As of 06/04/2026, Harvard Bioscience's market capitalization has reached $29.32 M. According to our data, Harvard Bioscience is the 35211th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 29.32 M |
| Revenue (ttm) | 85.53 M |
| Net Income (ttm) | -9,784,000 |
| Shares Out | 4.51 M |
| EPS (ttm) | -2.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/12/2026 |
Market Cap Chart
Data Updated: 06/04/2026
Harvard Bioscience's yearly market capitalization.
Harvard Bioscience has seen its market value drop from $264.9 M to $29.32 M since 2001, representing a total decrease of 88.93% and an annual compound decline rate (CAGR) of 8.62%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/04/2026 | $29.32 M | -3.02% | 35211 |
| 12/31/2025 | $29.8 M | -67.61% | 33865 |
| 12/31/2024 | $92 M | -59.72% | 23787 |
| 12/29/2023 | $228.4 M | 97.92% | 18015 |
| 12/30/2022 | $115.4 M | -59.89% | 21357 |
| 12/31/2021 | $287.7 M | 72.07% | 16721 |
| 12/31/2020 | $167.2 M | 44.01% | 17704 |
| 12/31/2019 | $116.1 M | -2.11% | 17348 |
| 12/31/2018 | $118.6 M | 3.04% | 16389 |
| 12/29/2017 | $115.1 M | 9.83% | 17254 |
Company Profile
Harvard Bioscience was founded in 1901 in United States.
The company went public on 12/07/2000
on the Nasdaq Stock Market.
With 339 employees, it focuses on Healthcare and aims to drive innovation in Medical Instruments & Supplies.
Frequently Asked Questions
-
What is Harvard Bioscience's (HBIO) current market cap?As of 06/04/2026, Harvard Bioscience (including the parent company, if applicable) has an estimated market capitalization of $29.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Harvard Bioscience (HBIO) rank globally by market cap?Harvard Bioscience global market capitalization ranking is approximately 35211 as of 06/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.